3rd ESTRO Forum 2015 acute vulvovaginitis. Only two patients presented hematuria in the follow-up, one documented to be radiation-induced, and the second was a superficial tumor relapse. Conclusions: Radiochemotherapy after TURB for invasive bladder cancer in very elderly patients with good general condition, is well tolerated and offers good 3-year overall survival rates. The high rates of locally complete response in these patients, makes RCT as an appropriate therapeutic option. The optimal schedule of concurrent chemotherapy needs to be ascertained.
Purpose/Objective: To identify changes in presentation, treatment and outcomes of older patients with low-grade glioma (LGG) over the past 50 years. Materials and Methods: Records of adults aged 55 or older upon diagnosis at Mayo Clinic between 1960 and 2011 with WHO grade II LGG were reviewed. They were grouped by those diagnosed before (group I: 1960-1989 ) and after (group II: 1990 (group II: -2011 ) the routine use of post-operative MRI. Results: Of the 852 adults diagnosed with LGG in our database, 94 were aged 55 or older. Median follow-up was 11.4 years. Pathologic diagnoses included astrocytoma in 55.3%, mixed oligoastrocytoma in 18% and oligodendroglioma in 26.7%. Gross total resection (GTR) was achieved in 9.6%, radical subtotal resection (rSTR) in 6.4%, subtotal resection (STR) in 20.2% and biopsy only in 63.8%. More patients in the modern era received GTR/rSTR (19.7% versus 7.1%), though the difference was not statistically significant. Median progression-free survival (PFS) was 3.0 years, with 5-and 10-year PFS rates of 31% and 10%, respectively. Median, 5-and 10-year overall survival (OS) was 4.1 years, 43% and 17%, respectively. PFS and OS were not statistically significantly different in group II compared with group I. Factors associated with PFS on univariate analysis included sensory/motor symptoms, astrocytoma histology, contrast enhancement and GTR/rSTR. Factors associated with OS on univariate analysis included astrocytoma histology, deep location, contrast enhancement, GTR/rSTR and PORT. On multivariate analysis, astrocytoma histology, contrast enhancement and GTR/rSTR remained statistically significantly associated with PFS. On multivariate analysis for OS, astrocytoma histology, deep location, contrast enhancement and GTR/rSTR remained statistically significant.
Conclusions: This retrospective series of older adults with
LGG confirms the poor prognosis of patients with these tumors. Despite reports of improving in outcomes for younger patients treated in the modern era, outcomes have not significantly improved for older patients. If medically safe, strong consideration should be given to maximally safe resection followed by adjuvant therapy. 
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